Similar Items: Comment on ‘Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Centre, Prospective, Observational Study (REVISE Study)’
- Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Center, Prospective, Observational Study (REVISE Study)
- Methodological Confounders in Evaluating Intra‐Class Therapeutic Interchange to Evogliptin: A Closer Look at the REVISE Sub‐Analysis
- Comment on ‘A Prospective Evaluation of Glucagon Stimulation Test Safety in Adults With Chronic Moderate‐to‐Severe Traumatic Brain Injury’
- Long‐Term Glycemic and Metabolic Profiles Observed During Imeglimin Therapy in Japanese Patients With Type 2 Diabetes Mellitus
- Overview of Cellular Transplantation in Diabetes Mellitus: Focus on the Metabolic Outcome
- Lipid Peroxidation and Antioxidant Status in Nonobese Type 2 Diabetes Mellitus